Today an article was published about a medical device that we are very proud to say that we have been very involved in developing. The device, called Vivoline LS1, can improve the quality of donated lungs, so that lungs that would otherwise be discarded can now be used.
In the autumn of 2008, the development of the lung evaluation device started. Now, a little more than two years later, it is already in use in two clinics in Sweden and one i Germany. The shortage of lungs is a big problem and we are delighted that the device can now come to use and help more people get new, healthy lungs.
Already at the very start, Gantus was a part of the development, as Peter Sebelius took the role of CEO and project manager of the new company. Other Gantus consultants have also taken part in the development, working with product documentation, risk analysis, biocompatibility testing and product design.